David Zawitz insider trades

Open-market stock purchases and sales by David Zawitz, Chief Operating Officer at Verrica Pharmaceuticals Inc, from SEC Form 4 filings since Dec 9, 2024.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -4%.

Recent trades

DateStockTradeValue
Aug 17, 2026VRCA Verrica Pharmaceuticals IncBought$29.9K
Jun 5, 2026VRCA Verrica Pharmaceuticals IncBought (not open market)—
Nov 25, 2025VRCA Verrica Pharmaceuticals IncBought$42.4K
Nov 25, 2025VRCA Verrica Pharmaceuticals IncBought$15.8K

Companies traded

  • VRCA Verrica Pharmaceuticals Inc: 3 buys, last Aug 17, 2026

Get free alerts when David Zawitz files a new trade →